This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).
Excellence in pharmaceutical outsourcing
from molecule to market

PCI is a respected industry leader and trusted partner providing a comprehensive range of outsourced pharmaceutical services from early stage development to long term commercial supply


Accelerate your drug to proof of concept with PCI's new Speed to StudyTM services

PCI's new Speed to StudyTM offering is designed to get your drug into the clinic quickly and efficiently so you can focus on collecting the early phase clinical data you need for your proof of concept

PCI has launched a new Webflow App and it's available now

Webflow is a market leading technology providing a comprehensive customer support portal which brings many benefits to our clients including access to a wide range of reports updated in real time and available 24/7, enabling more efficient and effective supply management.

Welcome to PCI Pharma Services

PCI is an integrated full-service provider and a trusted partner of many leading pharmaceutical companies globally; we offer unparalleled expertise and experience in taking compounds from the earliest stages of development through to commercial launch, delivering speed to market and commercial success for our customers.

Core services include: Analytical services, formulation development, clinical trial services, commercial manufacturing and packaging, QP services, supply chain management, storage and distribution. Customers may choose to use us as a complete development partner and benefit from our full range of services or choose any of our core services as a stand-alone offering.

PCI Unveils Clinical Center of Excellence

Expanded Clinical Services Facility in Rockford, IL to Support Growth and Flexibility with 30,000 additional sq ft We have officially... View Article

Significant Investments at Ireland Site

PCI Strengthens Position in Europe with Investment in Ireland Latest development at Dublin site positions it at forefront of EU... View Article

x